-The Economic Times A growing number of countries are adopting India's intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health. Although multinational companies have criticised India for being lax in enforcing intellectual property (IP) laws, countries such as China, Argentina and the Philippines are adopting similar provisions. Last month, China amended its IP laws, allowing local companies to produce low-cost versions...

-The Hindu About 40 networks and civil society groups from 16 districts of Rajasthan on Saturday demanded that the flagship free medicine supply scheme at government hospitals in the State be brought under an independent legislation or included in the Rajasthan Public Services Guarantee Act, 2011, to remove bottlenecks being faced for the past eight months. Activists under the banner of Jan Swasthya Abhiyan praised the scheme for its reach and objectives,...

When it comes to thrusting nuclear power down the throats of unwilling people, official India sets a record of violations of dignity and rights that is embarrassing. Which other government but India's maligns all anti-nuclear protesters as foreign-inspired and lacking any agency? Where else would the police file 107 FIRs against 55,795 peaceful anti-nuclear protesters, but at Koodankulam, charging 6,800 with "sedition" and "waging war against the State"? And which...

The cartoon controversy provides the possibility of interrogating the functioning of the academic system to understand its relationship with the downtrodden masses. A new deliberation is needed in order to make the academic world more sensitive and responsive towards the issues and concerns of the subaltern-oppressed communities. This will be an ethical incentive for the present-day dalit movement in India and can bring greater democratisation to the education system. Harish Wankhede...

-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...